Class 2 drug recall for batch of Rifadin rifampicin infusion
May 9 2016
A class 2 drug recall for a batch of Rifadin (rifampicin) infusion 600mg, manufactured by Aventis Pharma Ltd trading as Sanofi, has been issued.
Sanofi has issued the recall for the powder vial and 10ml solvent, with batch number A5545 and expiry date September 30 2019. It was first distributed on February 2.
The recall has been prompted “because an investigation of out of trend results indicated that it was contaminated with chilled water circulating in the jacket of the reactor during manufacture,” said the medicines regulator, the MHRA.
“Pharmacists are asked to quarantine any remaining stock of this batch and return it to the original supplier.”